Meta-epidemiology and the MetaBLIND study: Response to Tack

Area of Science:

• Clinical Trials Methodology
• Meta-Epidemiology
• Research Integrity

Background:

• Masking is a standard practice in randomized clinical trials (RCTs) to prevent bias.
• The extent of bias in non-masked RCTs remains a subject of investigation.
• Previous meta-epidemiological studies have explored various methodological aspects of RCTs.

Purpose of the Study:

• To investigate the impact of masking on effect estimates in randomized clinical trials (RCTs).
• To address comments and interpretations regarding the MetaBLIND study's findings on masking.
• To evaluate whether the MetaBLIND results justify abandoning masking as a safeguard.

Main Methods:

• Conducted a large-scale meta-epidemiological study (MetaBLIND) analyzing data from randomized clinical trials.
• Examined effect estimates in masked versus non-masked RCTs.
• Responded to specific critiques concerning the interpretation of meta-epidemiological findings.

Main Results:

• The MetaBLIND study found no statistically significant evidence of an impact of masking on effect estimates, on average.
• Critiques raised did not invalidate the core findings or necessitate a change in conclusions.
• The study's results are insufficient to recommend discontinuing the practice of masking in RCTs.

Conclusions:

• Masking may not significantly bias effect estimates in RCTs on average.
• The interpretation of meta-epidemiological studies requires careful consideration of common themes.
• Maintaining masking as a methodological safeguard in RCTs remains advisable despite the study's findings.